United Therapeutics | UTHR - 销售和管理费用

金融业

USD 591.17

USD 7.03B

现金及等价物

USD 1.19B

USD 99.1M

USD 2.88B

USD 624.3M

USD 200M

USD 241.3M

USD 334.2M

1.31K

EPS每股收益

USD 5.71

股本和储备

USD 6.28B

USD 733.4M

债务利息支出

USD 2.9M

USD 31.5M

USD 100M

USD 27.7B

USD 258.6M

USD 6.28B

USD 241.3M

普通股股本

USD 42.38M

19.41

USD 372.8M

USD 832.5M

销售和管理费用

USD 184.1M

USD 201.9M

贸易债权人

USD 520.2M

应收帐款人

USD 348.6M

	销售和管理费用	更改		日
Amarin	USD 18.97M		1.03M	2025-12
Ardelyx	USD 101.44M		827K	2026-06
Baxter International	USD 730M		5M	2026-09
Bayer	EUR 4.02B		53M	2026-09
BioCryst Pharmaceuticals	USD 63.98M		31.8M	2026-06
Biogen	USD 752M		42.3M	2026-09
BioMarin Pharmaceutical	USD 333.64M		61.91M	2026-09
Emergent BioSolutions	USD 182.8M		82.3M	2023-06
Gilead Sciences	USD 1.52B		70M	2026-06
GlaxoSmithKline	GBP 2.16B		39M	2026-09
Halozyme Therapeutics	USD 58.24M		1.24M	2026-09
Insmed	USD 253.03M		5.56M	2026-09
Ionis Pharmaceuticals	USD 154M		23.92M	2026-09
J&J	USD 6.25B		168M	2026-09
Lexicon Pharmaceuticals	USD 3.98M		195K	2025-12
Moderna	USD 282M		66M	2026-09
Omeros	USD 11.32M		2.48M	2024-09
Pfizer	USD 3.28B		132M	2026-09
PTC Therapeutics	USD 80.63M		6.74M	2026-06
Regeneron Pharmaceuticals	USD 662.1M		14.4M	2026-06
Sangamo BioSciences	USD 9.64M		1.83M	2024-06
Sarepta Therapeutics	USD 118.61M		11.01M	2026-09
Teva Pharmaceutical Industries	USD 1.01B		27M	2026-09
United Therapeutics	USD 184.1M		22.6M	2026-09
Vertex Pharmaceuticals	USD 556.3M		25.9M	2026-09